The Clorox Company (CLX)
NEUTRALFundamental
47
मूल्य
$106.19
मार्केट कैप
$12.98B
भाग 1 · कंपनी का मूल्य कितना है
अवलोकन
Clorox makes household staples sold under well-known names: bleach and cleaning sprays under its own Clorox brand, trash bags under Glad, charcoal under Kingsford, and personal-care and health products including Burt's Bees. It manufactures most of what it sells, ships it to large retailers, and relies on repeat, habitual purchases rather than one-off sales — a household restocks bleach or trash bags on a predictable cycle regardless of the wider economy.
यह पैसा कैसे कमाती है
Revenue comes from selling packaged goods to a concentrated set of large retailers, who then resell to shoppers. Margins depend on the cost of raw materials such as resin and chemicals, on manufacturing efficiency, and on holding shelf space and brand loyalty against cheaper private-label alternatives that retailers sell alongside Clorox's own products. The company reports results across four segments split by product category and by U.S. versus international markets.
सेगमेंट के अनुसार राजस्व
Cleaning and disinfecting products under Clorox, plus water filtration under Brita and vitamins under Natural Vitality.
Trash bags under Glad, cat litter under Fresh Step and Scoop Away, and charcoal under Kingsford.
Food products including Hidden Valley dressings, and personal care through Burt's Bees.
The same core product categories sold outside the United States, mainly in Latin America and Canada.
प्रतिस्पर्धी बढ़त (Moat)
ब्रांड · संकीर्णNames like Clorox, Glad and Kingsford have been the default choice on U.S. shelves for generations, which lets the company hold shelf space and charge more than an unbranded equivalent. The advantage is narrow: retailer store brands compete directly in nearly every category, and a large retailer with real pricing leverage can push back hard on Clorox's terms.
मांग को क्या चलाता है
डिफेंसिवCleaning products, trash bags and personal care items are routine, non-discretionary household purchases that people keep buying in a downturn, which makes volume relatively stable across the economic cycle. The bigger swings in results tend to come from input-cost inflation and from consumers trading down to private label when money is tight, not from skipping the purchase altogether.
प्रमुख जोखिम
- Retailer concentration — With Walmart alone worth nearly 27% of net sales, large retailers have the leverage to demand better pricing terms or to favour their own private-label products over Clorox's brands.
- Input cost and supply chain disruption — Volatile commodity, packaging, labour, energy and logistics costs, along with the risk of supply disruption from conflicts such as those in Ukraine, the Middle East, or tensions between China and Taiwan, can raise costs faster than prices can be adjusted.
- Cybersecurity — The company depends heavily on information technology systems and has already suffered a major cyberattack, in August 2023, that disrupted operations; a repeat incident could again halt production and shipments.
- Private-label competition — Store-brand alternatives, often priced well below Clorox's products, compete in nearly every category the company sells in, forcing continued spending on marketing and innovation to defend market share.
ग्राहक Concentration
शीर्ष ग्राहकों का राजस्व में 27% हिस्सा है
Walmart and its affiliates accounted for nearly 27% of net sales in fiscal 2025, giving a single retailer significant leverage over shelf placement, promotional terms and pricing.
खरीदने के पक्ष में तर्क
Buyers argue that Clorox's brands are habit-forming staples that hold shelf space no private label can fully dislodge, and that the company's cost-savings programme and full recovery from the 2023 cyberattack position it to grow margins even on roughly flat sales.
बेचने के पक्ष में तर्क
Sellers worry that with Walmart alone worth over a quarter of sales, Clorox has limited room to push back on retailer demands, and that persistent private-label competition plus input-cost inflation could keep squeezing volumes and margins at the same time.
Written by the editors, published on 18 अगस्त 2026
Direct competitors
Who this company fights with for the same customers
No editorial profile for this company yet
No competitor list for this company yet.
बैलेंस शीट और तरलता
राजस्व
$6.76B
पिछले 12 महीने (31/3/2026 तक)
शुद्ध आय
$756M
पिछले 12 महीने (31/3/2026 तक)
Free Cash Flow
$761M
कुल इक्विटी
$321M
कुल देनदारियाँ
$5.08B
Current Ratio
0.84
Interest Coverage
-
Debt/EBITDA
3.94
Earnings Per Share
राजस्व और शुद्ध आय
Free Cash Flow
आय विवरण
ऐतिहासिक विवरण
समय के साथ मार्जिन
समय के साथ ऋण
ऋण कितना भारी है
वृद्धि तालिका
वृद्धि — राजस्व
Fair Value अनुमान
Fair Value
$110.05
वर्तमान मूल्य
$106.19
Margin of Safety
+3.5%
Fair Value सीमा
$71.53 - $148.56
अनुमान विधियाँ
मूल्यांकन मेट्रिक्स
P/E Ratio
17.40
ROE
252.3%
P/B Ratio
40.43
P/FCF
34.10
Gross Margin
43.8%
ROIC
-
लाभप्रदता Radar
Value Creation (Economic Moat)
ROIC
-
WACC
6.3%
ROIC − WACC
-
Fundamental विश्लेषण मानदंड
पास (11)
- EPS shows upward trend
- Gross Margin 43.8%
- Positive Free Cash Flow
- Current Ratio
- Debt/EBITDA
- Return on Tangible Assets
- ROE 181.1%
- Earnings Quality (OCF/NI) 0.76
- Share Dilution -0.2%
- Net Margin Trend 11.2% vs 9.9%
- Piotroski F-Score 8/9
फेल (12)
- EPS CAGR 4.22%
- Price CAGR -1.17%
- P/FCF 34.10
- P/B Ratio 40.43
- Debt/Equity ratio
- CapEx intensity
- Low reliance on intangibles
- Price below Graham Number
- DCF valuation (Fairly valued)
- Revenue Growth 5Y -1.8%
- Analyst Consensus 4% Buy
- Earnings Surprise avg 1.8%
अनुपलब्ध (5)
- ROIC NaN%
- Dividend Payout NaN%
- Operating Margin NaN%
- Interest Coverage
- PEG Ratio (need PE > 0 and growth > 0)
Piotroski F-Score
मजबूत वित्तीय स्वास्थ्य
Earnings गुणवत्ता
मध्यम: मुनाफे और नकदी के बीच कुछ अंतर
शेयर Dilution
शेयर वापस खरीद रही है। शेयरधारक अनुकूल
प्रशासन
कार्यकारी टीम
| नाम | पद | आयु |
|---|---|---|
| Ms. Linda J. Rendle | CEO & Chairman | 47 |
| Mr. Luc Bellet | Executive VP & CFO | 46 |
| Ms. Nina Barton | Executive VP and Chief Growth & Strategy Officer | 51 |
| Ms. Laura E. Peck | VP, Chief Accounting Officer & Corporate Controller | 48 |
| Ms. Kirsten M. Marriner | Executive VP & Chief Administrative Officer | 52 |
| Ms. Lisah Burhan | Vice President of Investor Relations | - |
Audit जोखिम
7
बोर्ड जोखिम
3
मुआवजा जोखिम
6
शेयरधारक अधिकार जोखिम
8
भाग 2 · कीमत और खरीदने का समय
यह हिस्सा यह नहीं बताता कि कंपनी अच्छी है या नहीं: यह तय करने में मदद करता है कि उसे कब खरीदें, जब फंडामेंटल आपको आश्वस्त कर चुके हों। इसमें: तकनीकी विश्लेषण, संभावना, ऐतिहासिक गिरावट, गामा एक्सपोज़र।
Latest News
Recent headlines for CLX, sourced from Markets Gazette.
- 22d agoPOSITIVEClorox Expects Full-Year Sales Boost From Purell Deal
The Clorox Company announced fiscal fourth-quarter earnings that surpassed analyst forecasts, signaling resilience despite challenges. While sales volumes were down and the recent acquisition of GOJO Industries, the maker of Purell, incurred additional logistics costs, the overall financial performance indicates effective management. The company anticipates a full-year sales boost stemming from the Purell integration, suggesting a positive outlook for future revenue streams. Investors will be watching the successful integration of GOJO and its impact on Clorox's market position and profitability in the coming quarters.
via Markets Gazette